Animal models for aberrations of gonadotropin action

Reviews in Endocrine and Metabolic Disorders

Volumn 12, Issue 4, 2011, Pages 245-258

  Peltoketo, Hellevi ^a   Zhang, Fu Ping ^b   Rulli, Susana B ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TURKU   (Finland)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

Gonadotropin; Ovary. Testis; Pituitary. Genetically modified; Receptor

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADOTROPIN; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE;

ARTICLE; CARCINOGENESIS; DISEASE MODEL; GENETIC DISORDER; HYPERGONADOTROPIC HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MALE ACCESSORY GLAND; NONHUMAN; OVARY; OVARY FOLLICLE; PHENOTYPE; TESTIS; UROGENITAL SYSTEM;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOCRINE SYSTEM DISEASES; FEMALE; GONADOTROPINS; HUMANS; MALE; MICE; MICE, TRANSGENIC; OVARY; PITUITARY GLAND; TESTIS;

EID: 84855692855     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-011-9174-4     Document Type: Article

References (87)

1. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet. 1997;15(2):201-4. doi:10.1038/ng0297-201. (Pubitemid 27061644)
2. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA. 1998;95(23):13612-7. (Pubitemid 28523020)
3. Abel MH, Wootton AN, Wilkins V, Huhtaniemi I, Knight PG, Charlton HM. The effect of a null mutation in the folliclestimulating hormone receptor gene on mouse reproduction. Endocrinology. 2000;141(5):1795-803. (Pubitemid 32274410)
4. Ma X, Dong Y, Matzuk MM, Kumar TR. Targeted disruption of luteinizing hormone beta-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility. Proc Natl Acad Sci USA. 2004;101(49):17294-9. doi:10.1073/pnas.0404743101. (Pubitemid 39627813)
5. Zhang FP, Poutanen M,Wilbertz J, Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol. 2001;15(1):172-83. (Pubitemid 32156050)
6. Lei ZM, Mishra S, Zou W, Xu B, Foltz M, Li X, et al. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol. 2001;15(1):184-200. (Pubitemid 32156051)
7. Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev. 2000;21 (5):551-83.
8. Kumar TR.What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice? Reproduction. 2005;130(3):293-302. doi:10.1530/rep.1.00660. (Pubitemid 41320754)
9. Tena-Sempere M. GPR54 and kisspeptin in reproduction. Hum Reprod Update. 2006;12(5):631-9. doi:10.1093/humupd/dml023. (Pubitemid 44288712)
10. Bouligand J, Ghervan C, Guiochon-Mantel A, Young J. Hypogonadotropic hypogonadism and GNRH1 mutations in mice and humans. Front Horm Res. 2010;39:111-20. doi:10.1159/ 000312697.
11. Lei L, Jin S, Mayo KE, Woodruff TK. The interactions between the stimulatory effect of follicle-stimulating hormone and the inhibitory effect of estrogen onmouse primordial folliculogenesis. Biol Reprod. 2010;82(1):13-22. doi:10.1095/biolreprod.109.077404.
12. Motta PM, Makabe S, Nottola SA. The ultrastructure of human reproduction. I. The natural history of the female germ cell: origin, migration and differentiation inside the developing ovary. Hum Reprod Update. 1997;3(3):281-95. (Pubitemid 27437932)
13. Roy SK, Albee L. Requirement for follicle-stimulating hormone action in the formation of primordial follicles during perinatal ovarian development in the hamster. Endocrinology. 2000;141 (12):4449-56. (Pubitemid 32055120)
14. Balla A, Danilovich N, Yang Y, Sairam MR. Dynamics of ovarian development in the FORKO immature mouse: Structural and functional implications for ovarian reserve. Biol Reprod. 2003;69 (4):1281-93. doi:10.1095/biolreprod.103.015552. (Pubitemid 37173863)
15. Tingen C, Kim A, Woodruff TK. The primordial pool of follicles and nest breakdown in mammalian ovaries. Mol Hum Reprod. 2009;15(12):795-803. doi:10.1093/molehr/gap073.
16. WangY, Newton H, Spaliviero JA,Allan CM, Marshan B,Handelsman DJ, et al. Gonadotropin control of inhibin secretion and the relationship to follicle type and number in the hpg mouse. Biol Reprod. 2005;73(4):610-8. doi:10.1095/ biolreprod.105.039602. (Pubitemid 41356118)
17. Flaws JA, Abbud R, Mann RJ, Nilson JH, Hirshfield AN. Chronically elevated luteinizing hormone depletes primordial follicles in the mouse ovary. Biol Reprod. 1997;57(5):1233-7. (Pubitemid 27461218)
18. Peltoketo H, Strauss L, Karjalainen R, Zhang M, Stamp GW, Segaloff DL, et al. Female mice expressing constitutively active mutants of FSH receptor present with a phenotype of premature follicle depletion and estrogen excess. Endocrinology. 2010;151 (4):1872-83. doi:10.1210/en.2009-0966.
19. Oktay K, Briggs D, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab. 1997;82(11):3748-51 (Pubitemid 27509366)
20. O'Shaughnessy PJ, Dudley K, Rajapaksha WR. Expression of follicle stimulating hormone-receptor mRNA during gonadal development. Mol Cell Endocrinol. 1996;125(1-2):169-75. (Pubitemid 27038275)
21. Gelety TJ, Magoffin DA. Ontogeny of steroidogenic enzyme gene expression in ovarian theca-interstitial cells in the rat: Regulation by a paracrine theca-differentiating factor prior to achieving luteinizing hormone responsiveness. Biol Reprod. 1997;56(4):938-45. (Pubitemid 27150423)
22. McTavish KJ, Jimenez M, Walters KA, Spaliviero J, Groome NP, Themmen AP, et al. Rising follicle-stimulating hormone levels with age accelerate female reproductive failure. Endocrinology. 2007;148(9):4432-9. (Pubitemid 47295708)
23. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology. 2000;141(11):4295-308.
24. Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byrne MC, et al. Transgenic models to study gonadotropin function: The role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Mol Endocrinol. 1999;13(6):851-65. (Pubitemid 30645304)
25. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21(2):200-14. (Pubitemid 32275595)
26. Visser JA, Themmen AP. Anti-Mullerian hormone and folliculogenesis. Mol Cell Endocrinol. 2005;234(1-2):81-6. doi:10.1016/j. mce.2004.09.008.
27. De Leener A, Montanelli L, Van Durme J, Chae H, Smits G, Vassart G, et al. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab. 2006;91(2):555-62. doi:10.1210/jc.2005-1580. (Pubitemid 43236926)
28. Pakarainen T, Zhang FP, Nurmi L, Poutanen M, Huhtaniemi I. Knockout of luteinizing hormone receptor abolishes the effects of follicle-stimulating hormone on preovulatory maturation and ovulation of mouse graafian follicles. Mol Endocrinol. 2005;19 (10):2591-602. (Pubitemid 41362671)
29. Galway AB, Lapolt PS, Tsafriri A, Dargan CM, Boime I, Hsueh AJ. Recombinant follicle-stimulating hormone induces ovulation and tissue plasminogen activator expression in hypophysectomized rats. Endocrinology. 1990;127(6):3023-8.
30. Matzuk MM, DeMayo FJ, Hadsell LA, Kumar TR. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice. Biol Reprod. 2003;69(1):338-46. doi:10.1095/biolreprod.102.013953. (Pubitemid 36806840)
31. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA. 1995;92(5):1322-6.
32. Meehan TP, Harmon BG, Overcast ME, Yu KK, Camper SA, Puett D, et al. Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex. J Mol Endocrinol. 2005;34(2):489-503. doi:10.1677/jme.1.01669. (Pubitemid 40585197)
33. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M, Huhtaniemi I. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology. 2002;143(10):4084-95. (Pubitemid 35244387)
34. Risma KA, Hirshfield AN, Nilson JH. Elevated luteinizing hormone in prepubertal transgenic mice causes hyperandrogenemia, precocious puberty, and substantial ovarian pathology. Endocrinology. 1997;138(8):3540-7. (Pubitemid 27345710)
35. Huhtaniemi I. Are gonadotrophins tumorigenic-a critical review of clinical and experimental data. Mol Cell Endocrinol. 2010;329 (1-2):56-61. doi:10.1016/j.mce.2010.04.028.
36. Huhtaniemi I, Rulli S, Ahtiainen P, Poutanen M. Multiple sites of tumorigenesis in transgenic mice overproducing hCG. Mol Cell Endocrinol. 2005;234(1-2):117-26.
37. Mann RJ, Keri RA, Nilson JH. Consequences of elevated luteinizing hormone on diverse physiological systems: Use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology. Recent Prog Horm Res. 2003;58:343-75. (Pubitemid 37339317)
38. Mikola M, Kero J, Nilson JH, Keri RA, Poutanen M, Huhtaniemi I. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene. Oncogene. 2003;22(21):3269-78. (Pubitemid 36712939)
39. Aravindakshan J, Chen XL, Sairam MR. Chronology and complexities of ovarian tumorigenesis in FORKO mice: Age-dependent gene alterations and progressive dysregulation ofMajor Histocompatibility Complex (MHC) Class I and II profiles. Mol Cell Endocrinol. 2010;329(1-2):37-46. doi:10.1016/j.mce.2010. 05.015.
40. Danilovich N, Roy I, Sairam MR. Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice. Endocrinology. 2001;142(8):3673-84. (Pubitemid 32681779)
41. Radu A, Pichon C, Camparo P, Antoine M, Allory Y, Couvelard A, et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med. 2010;363(17):1621-30. doi:10.1056/NEJMoa1001283.
42. Pakarainen T, Zhang FP, Makela S, Poutanen M, Huhtaniemi I. Testosterone replacement therapy induces spermatogenesis and partially restores fertility in luteinizing hormone receptor knockout mice. Endocrinology. 2005;146(2):596-606. (Pubitemid 40129815)
43. Rivero-Muller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, et al. Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci USA. 2010;107(5):2319-24. doi:10.1073/pnas.0906695106.
44. Rulli SB, Ahtiainen P, Makela S, Toppari J, Poutanen M, Huhtaniemi I. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin. Endocrinology. 2003;144 (11):4980-90. doi:10.1210/en.2003-0403. (Pubitemid 37378413)
45. Ahtiainen P, Rulli SB, Shariatmadari R, Pelliniemi LJ, Toppari J, Poutanen M, et al. Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: A study on hCG overexpressing transgenic mice. Oncogene. 2005;24(49):7301-9. (Pubitemid 41622234)
46. Kumar TR, Varani S, Wreford NG, Telfer NM, de Kretser DM, Matzuk MM. Male reproductive phenotypes in double mutant mice lacking both FSHbeta and activin receptor IIA. Endocrinology. 2001;142(8):3512-8. (Pubitemid 32681759)
47. Wreford NG, Rajendra Kumar T, Matzuk MM, de Kretser DM. Analysis of the testicular phenotype of the follicle-stimulating hormone beta-subunit knockout and the activin type II receptor knockout mice by stereological analysis. Endocrinology. 2001;142 (7):2916-20. (Pubitemid 32575528)
48. Baker PJ, Pakarinen P, Huhtaniemi IT, Abel MH, Charlton HM, Kumar TR, et al. Failure of normal Leydig cell development in follicle-stimulating hormone (FSH) receptor-deficient mice, but not FSHbeta-deficient mice: Role for constitutive FSH receptor activity. Endocrinology. 2003;144(1):138-45. (Pubitemid 36076102)
49. Krishnamurthy H, Danilovich N, Morales CR, Sairam MR. Qualitative and quantitative decline in spermatogenesis of the follicle-stimulating hormone receptor knockout (FORKO) mouse. Biol Reprod. 2000;62(5):1146-59. (Pubitemid 30238464)
50. Xing W, Krishnamurthy H, Sairam MR. Role of follitropin receptor signaling in nuclear protein transitions and chromatin condensation during spermatogenesis. Biochem Biophys Res Commun. 2003;312(3):697-701. doi:10.1016/j.bbrc.2003.10.177. (Pubitemid 37468227)
51. Allan CM, Haywood M, Swaraj S, Spaliviero J, Koch A, Jimenez M, et al. A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions. Endocrinology. 2001;142(6):2213-20. (Pubitemid 32473074)
52. Allan CM, Garcia A, Spaliviero J, Zhang FP, Jimenez M, Huhtaniemi I, et al. Complete Sertoli cell proliferation induced by follicle-stimulating hormone (FSH) independently of luteinizing hormone activity: Evidence from genetic models of isolated FSH action. Endocrinology. 2004;145(4):1587-93. (Pubitemid 38402364)
53. Rulli SB, Huhtaniemi I. What have gonadotrophin overexpressing transgenic mice taught us about gonadal function? Reproduction. 2005;130(3):283-91. (Pubitemid 41320753)
54. Mohammad HP, Abbud RA, Parlow AF, Lewin JS, Nilson JH. Targeted overexpression of luteinizing hormone causes ovarydependent functional adenomas restricted to cells of the Pit-1 lineage. Endocrinology. 2003;144(10):4626-36. doi:10.1210/en.2003-0357. (Pubitemid 37204862)
55. Ahtiainen P, Sharp V, Rulli SB, Rivero-Muller A, Mamaeva V, Roytta M, et al. Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levels. Endocr Relat Cancer. 2010;17 (3):611-21. doi:10.1677/ERC-10-0016.
56. Gonzalez B, Ratner LD, Di Giorgio NP, Poutanen M, Huhtaniemi IT, Calandra RS, et al. Endogenously elevated androgens alter the developmental programming of the hypothalamic-pituitary axis in male mice. Mol Cell Endocrinol. 2011;332(1-2):78-87. doi:10.1016/j.mce.2010.09.016.
57. Narayan P, Gray J, Puett D. Yoked complexes of human choriogonadotropin and the lutropin receptor: Evidence that monomeric individual subunits are inactive. Mol Endocrinol. 2002;16(12):2733-45. (Pubitemid 36024178)
58. Abbud RA, Ameduri RK, Rao JS, Nett TM, Nilson JH. Chronic hypersecretion of luteinizing hormone in transgenic mice selectively alters responsiveness of the alpha-subunit gene to gonadotropin-releasing hormone and estrogens. Mol Endocrinol. 1999;13(9):1449-59. (Pubitemid 30654813)
59. Heaney AP, Fernando M, Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest. 2002;109(2):277-83. doi:10.1172/JCI14264. (Pubitemid 34083748)
60. Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S, et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell. 2006;9(6):459-71. doi:10.1016/j.ccr.2006.04.024. (Pubitemid 43832192)
61. Milliken EL, Ameduri RK, Landis MD, Behrooz A, Abdul-Karim FW, Keri RA. Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinology. 2002;143(9):3671-80. (Pubitemid 34925744)
62. Kuorelahti A, Rulli S, Huhtaniemi I, Poutanen M. Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary Gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation. Endocrinology. 2007;148 (8):3694-703. doi:10.1210/en.2007-0249. (Pubitemid 47105831)
63. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, et al. FSH directly regulates bone mass. Cell. 2006;125(2):247-60. doi:10.1016/j.cell.2006. 01.051.
64. Iqbal J, Sun L, Zaidi M. Commentary-FSH and bone 2010: Evolving evidence. Eur J Endocrinol. 2010;163(1):173-6. doi:10.1530/EJE-10-0397.
65. Allan CM, Kalak R, Dunstan CR, McTavish KJ, Zhou H, Handelsman DJ, et al. Follicle-stimulating hormone increases bone mass in female mice. Proc Natl Acad Sci USA. 2010;107 (52):22629-34. doi:10.1073/pnas.1012141108.
66. Bernichtein S, Petretto E, Jamieson S, Goel A, Aitman TJ, Mangion JM, et al. Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci. Endocrinology. 2008;149(2):651-61. doi:10.1210/en.2007-0925. (Pubitemid 351159319)
67. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, et al. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest. 2000;105(5):633-41. doi:10.1172/JCI7716. (Pubitemid 30146510)
68. Bernichtein S, Peltoketo H, Huhtaniemi I. Adrenal hyperplasia and tumours in mice in connection with aberrant pituitary-gonadal function. Mol Cell Endocrinol. 2009;300(1-2):164-8. doi:10.1016/j.mce.2008.10.005.
69. Barron AM, Verdile G, Martins RN. The role of gonadotropins in Alzheimer's disease: Potential neurodegenerative mechanisms. Endocr. 2006;29(2):257-69. doi:10.1385/ENDO:29:2:257. (Pubitemid 44109213)
70. Lei ZM, Rao CV, Kornyei JL, Licht P, Hiatt ES. Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology. 1993;132(5):2262-70. (Pubitemid 23133280)
71. Lei ZM, Rao CV. Neural actions of luteinizing hormone and human chorionic gonadotropin. Semin Reprod Med. 2001;19 (1):103-9. doi:10.1055/s-2001-13917. (Pubitemid 32489051)
72. Bowen RL, Isley JP, Atkinson RL. An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol. 2000;12(4):351-4. doi:jne461. (Pubitemid 30156528)
73. Short RA, Bowen RL, O'Brien PC, Graff-Radford NR. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc. 2001;76(9):906-9. (Pubitemid 32825912)
74. Haasl RJ, Ahmadi MR, Meethal SV, Gleason CE, Johnson SC, Asthana S, et al. A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele. BMC Med Genet. 2008;9:37. doi:10.1186/1471-2350-9-37. (Pubitemid 351737014)
75. Bowen RL, Verdile G, Liu T, Parlow AF, Perry G, Smith MA, et al. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem. 2004;279(19):20539-45. doi:10.1074/ jbc.M311993200. (Pubitemid 38623501)
76. Lin J, Li X, Yuan F, Lin L, Cook CL, Rao ChV, et al. Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease. J Neuropathol Exp Neurol. 2010;69(3):253-61. doi:10.1097/NEN.0b013e3181d072cf.
77. doi:10.1097/NEN.0b013e3181d072cf. 77. Tam J, Danilovich N, Nilsson K, Sairam MR, Maysinger D. Chronic estrogen deficiency leads to molecular aberrations related to neurodegenerative changes in follitropin receptor knockout female mice. Neuroscience. 2002;114(2):493-506. doi: S0306452202002786. (Pubitemid 35245427)
78. Zhang FP, Pakarainen T, Poutanen M, Toppari J, Huhtaniemi I. The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis. Proc Natl Acad Sci USA. 2003;100(23):13692-7. doi:10.1073/ pnas.2232815100. (Pubitemid 37444801)
79. d'Anglemont de Tassigny X, Fagg LA, Dixon JP, Day K, Leitch HG, Hendrick AG, et al. Hypogonadotropic hypogonadism in mice lacking a functional Kiss1 gene. Proc Natl Acad Sci USA. 2007;104(25):10714-9. doi:10.1073/pnas.0704114104. (Pubitemid 47185730)
80. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno Jr. JS, Shagoury JK, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349(17):1614-27. doi:10.1056/ NEJMoa035322. (Pubitemid 37303886)
81. Funes S, Hedrick JA, Vassileva G, Markowitz L, Abbondanzo S, Golovko A, et al. The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem Biophys Res Commun. 2003;312(4):1357-63. doi:S0006291X03024070. (Pubitemid 37490966)
82. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA, Fink G. Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature. 1977;269(5626):338-40. (Pubitemid 8178658)
83. Pask AJ, Kanasaki H, Kaiser UB, Conn PM, Janovick JA, Stockton DW, et al. A novel mouse model of hypogonadotrophic hypogonadism: N-ethyl-N-nitrosourea- induced gonadotropinreleasing hormone receptor gene mutation. Mol Endocrinol. 2005;19(4):972-81. doi:10.1210/me.2004-0192. (Pubitemid 40397061)
84. Wu S, Wilson MD, Busby ER, Isaac ER, Sherwood NM. Disruption of the single copy gonadotropin-releasing hormone receptor in mice by gene trap: Severe reduction of reproductive organs and functions in developing and adult mice. Endocrinology. 2010;151(3):1142-52. doi:10.1210/en.2009-0598.
85. Allan CM, Wang Y, Jimenez M, Marshan B, Spaliviero J, Illingworth P, et al. Follicle-stimulating hormone increases primordial follicle reserve in mature female hypogonadal mice. J Endocrinol. 2006;188(3):549-57. doi:10.1677/joe.1. 06614.
86. Haywood M, Tymchenko N, Spaliviero J, Koch A, Jimenez M, Gromoll J, et al. An activated human follicle-stimulating hormone (FSH) receptor stimulates FSH-like activity in gonadotropin-deficient transgenic mice. Mol Endocrinol. 2002;16(11):2582-91. (Pubitemid 35266076)
87. Allan CM, Lim P, Robson M, Spaliviero J, Handelsman DJ. Transgenic mutant D567G but not wild-type human FSH receptor overexpression provides FSH-independent and promiscuous glycoprotein hormone Sertoli cell signaling. Am J Physiol Endocrinol Metab. 2009;296(5):E1022-8. doi:10.1152/ ajpendo.90941.2008.